{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:41:42Z","timestamp":1793814102043,"version":"4.6.1"},"reference-count":160,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ejso.2023.107292","type":"journal-article","created":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T11:46:06Z","timestamp":1701085566000},"page":"107292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"title":["European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0035-0679","authenticated-orcid":false,"given":"Isabel T.","family":"Rubio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"Wyld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Marotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Athanasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1371-1595","authenticated-orcid":false,"given":"Peter","family":"Regitnig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Catanuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan W.","family":"Schoones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Zambon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Camps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Santini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Dietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6545-9427","authenticated-orcid":false,"given":"Francesco","family":"Sardanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein","family":"Smidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3991-0768","authenticated-orcid":false,"given":"Nisha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer M.","family":"Shaaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejso.2023.107292_bib1","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/ijc.25801","article-title":"Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening","volume":"129","author":"Rakha","year":"2011","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2023.107292_bib2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10549-018-05071-1","article-title":"Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)","volume":"174","author":"Rageth","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.ejso.2023.107292_bib3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.breast.2010.12.003","article-title":"Positive predictive value for malignancy on surgical excision of breast lesions of uncertain malignant potential (B3) diagnosed by stereotactic vacuum-assisted needle core biopsy (VANCB): a large multi-institutional study in Italy","volume":"20","author":"Bianchi","year":"2011","journal-title":"Breast"},{"issue":"7","key":"10.1016\/j.ejso.2023.107292_bib4","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ejso.2022.04.005","article-title":"The positive predictive value of vacuum assisted biopsy (VAB) in predicting final histological diagnosis for breast lesions of uncertain malignancy (B3 lesions): a systematic review & meta-analysis","volume":"48","author":"Cullinane","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2023.107292_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2020.109258","article-title":"Role of vacuum assisted excision in minimising overtreatment of ductal atypias","volume":"131","author":"McMahon","year":"2020","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1016\/j.ejso.2023.107292_bib6","article-title":"High-risk lesions of the breast: concurrent diagnostic tools and management recommendations","volume":"12","author":"Catanzariti","year":"2021","journal-title":"Insights Imag"},{"issue":"24","key":"10.1016\/j.ejso.2023.107292_bib7","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individualized probabilities of developing breast cancer for white females who are being examined annually","volume":"81","author":"Gail","year":"1989","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.ejso.2023.107292_bib8","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","article-title":"A\u00a0breast cancer prediction model incorporating familial and personal risk factors","volume":"23","author":"Tyrer","year":"2004","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.ejso.2023.107292_bib9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJMsr1407164","article-title":"Atypical hyperplasia of the breast--risk assessment and management options","volume":"372","author":"Hartmann","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2023.107292_bib10","doi-asserted-by":"crossref","first-page":"i1152","DOI":"10.1136\/bmj.i1152","article-title":"The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines","volume":"352","author":"Brouwers","year":"2016","journal-title":"Bmj"},{"issue":"4","key":"10.1016\/j.ejso.2023.107292_bib11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.ejso.2023.107292_bib12","doi-asserted-by":"crossref","first-page":"684","DOI":"10.2214\/AJR.06.0809","article-title":"Underestimation of atypical ductal hyperplasia at MRI-guided 9-gauge vacuum-assisted breast biopsy","volume":"188","author":"Liberman","year":"2007","journal-title":"AJR Am J Roentgenol"},{"issue":"13","key":"10.1016\/j.ejso.2023.107292_bib13","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1001\/jama.2012.388","article-title":"Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk","volume":"307","author":"Berg","year":"2012","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ejso.2023.107292_bib14","doi-asserted-by":"crossref","first-page":"7388","DOI":"10.1007\/s00330-022-08868-3","article-title":"Contrast-enhanced mammography for the assessment of screening recalls: a two-centre study","volume":"32","author":"Cozzi","year":"2022","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.ejso.2023.107292_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10549-018-05071-1","article-title":"Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)","volume":"174","author":"Rageth","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejso.2023.107292_bib16","series-title":"WHO. Breast tumours WHO classification of tumours","year":"2019"},{"key":"10.1016\/j.ejso.2023.107292_bib17","series-title":"WHO classification of tumours, WHO. Breast tumours","year":"2019"},{"key":"10.1016\/j.ejso.2023.107292_bib18","series-title":"Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening","author":"Royal College of Pathologists","year":"2021"},{"issue":"4","key":"10.1016\/j.ejso.2023.107292_bib19","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12282-018-00943-2","article-title":"Atypical ductal hyperplasia and the risk of underestimation: tissue sampling method, multifocality, and associated calcification significantly influence the diagnostic upgrade rate based on subsequent surgical specimens","volume":"26","author":"Rageth","year":"2019","journal-title":"Breast Cancer"},{"issue":"6","key":"10.1016\/j.ejso.2023.107292_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11061120","article-title":"Atypical ductal hyperplasia after vacuum-assisted breast biopsy: can we reduce the upgrade to breast cancer to an acceptable rate?","volume":"11","author":"Nicosia","year":"2021","journal-title":"Diagnostics"},{"issue":"4","key":"10.1016\/j.ejso.2023.107292_bib21","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1245\/s10434-020-09107-z","article-title":"Prospective multicenter study validate a prediction model for surgery uptake among women with atypical breast lesions","volume":"28","author":"Uzan","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2023.107292_bib22","article-title":"Risk of breast cancer in selected women with atypical ductal hyperplasia who do not undergo surgical excision","author":"Kilgore","year":"2021","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2023.107292_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/CCI.18.00083","article-title":"Prediction of atypical ductal hyperplasia upgrades through a machine learning approach to reduce unnecessary surgical excisions","volume":"2","author":"Harrington","year":"2018","journal-title":"JCO Clin Cancer Inform"},{"issue":"1","key":"10.1016\/j.ejso.2023.107292_bib24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1148\/radiol.2019190748","article-title":"Upgrade rate of percutaneously diagnosed pure atypical ductal hyperplasia: systematic review and meta-analysis of 6458 lesions","volume":"294","author":"Schiaffino","year":"2020","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.ejso.2023.107292_bib25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1159\/000524879","article-title":"AGO recommendations for the diagnosis and treatment of patients with early breast cancer: update 2022","volume":"17","author":"Ditsch","year":"2022","journal-title":"Breast Care"},{"issue":"11","key":"10.1016\/j.ejso.2023.107292_bib26","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nrclinonc.2015.161","article-title":"Surgical treatment of nonpalpable primary invasive and in situ breast cancer","volume":"12","author":"Ahmed","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2023.107292_bib27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00428-023-03566-x","article-title":"Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)","volume":"483","author":"Elfgen","year":"2023","journal-title":"Virchows Arch"},{"issue":"8","key":"10.1016\/j.ejso.2023.107292_bib28","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.crad.2018.04.004","article-title":"NHS Breast Screening multidisciplinary working group guidelines for the diagnosis and management of breast lesions of uncertain malignant potential on core biopsy (B3 lesions)","volume":"73","author":"Pinder","year":"2018","journal-title":"Clin Radiol"},{"issue":"11","key":"10.1016\/j.ejso.2023.107292_bib29","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nrclinonc.2015.161","article-title":"Surgical treatment of nonpalpable primary invasive and in situ breast cancer","volume":"12","author":"Ahmed","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ejso.2023.107292_bib30","series-title":"Comprehensive cancer Network clinical practice guidelines in Oncology","author":"National","year":"2023"},{"issue":"33","key":"10.1016\/j.ejso.2023.107292_bib31","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1200\/JCO.2015.61.4743","article-title":"Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk","volume":"33","author":"King","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2023.107292_bib32","first-page":"119","volume":"18","author":"Carder","year":"2012","journal-title":"Pleom Lobular Carcinoma in Situ Diagnost Histopathol"},{"key":"10.1016\/j.ejso.2023.107292_bib33","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.breast.2017.12.011","article-title":"Pleomorphic LCIS what do we know? A UK multicenter audit of pleomorphic lobular carcinoma in situ","volume":"38","author":"Masannat","year":"2018","journal-title":"Breast"},{"issue":"8","key":"10.1016\/j.ejso.2023.107292_bib34","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/PAS.0000000000001493","article-title":"Apocrine variant of pleomorphic lobular carcinoma in situ: further clinical, histopathologic, immunohistochemical, and molecular characterization of an emerging entity","volume":"44","author":"Zhong","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.ejso.2023.107292_bib35","first-page":"730","article-title":"Multicentric and bilateral appearance of lobular carcinoma in situ of the breast","volume":"82","author":"Anderson","year":"1974","journal-title":"Acta Pathol Microbiol Scand"},{"issue":"24","key":"10.1016\/j.ejso.2023.107292_bib36","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1200\/JCO.2005.04.038","article-title":"Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data","volume":"23","author":"Chuba","year":"2005","journal-title":"J\u00a0Clin Oncol : Off J Am Soc Clin Oncol"},{"issue":"9352","key":"10.1016\/j.ejso.2023.107292_bib37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(03)12230-1","article-title":"Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study","volume":"361","author":"Page","year":"2003","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ejso.2023.107292_bib38","first-page":"1919","article-title":"E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain","volume":"13","author":"Berx","year":"1996","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.ejso.2023.107292_bib39","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/01.pas.0000213386.63160.3f","article-title":"Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin","volume":"31","author":"Dabbs","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.ejso.2023.107292_bib40","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0b013e3182918a2b","article-title":"Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry","volume":"37","author":"Dabbs","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.ejso.2023.107292_bib41","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1365-2559.2008.03158.x","article-title":"Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening","volume":"53","author":"El-Sayed","year":"2008","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.ejso.2023.107292_bib42","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ejso.2011.01.009","article-title":"Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast--a review","volume":"37","author":"Hussain","year":"2011","journal-title":"Eur J Surg Oncol : J Eur Soc Surg Oncol Brit Associat Surg Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2023.107292_bib43","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jacr.2020.07.036","article-title":"Risk for upgrade to malignancy after breast core needle biopsy diagnosis of lobular neoplasia: a systematic review and meta-analysis","volume":"17","author":"Shehata","year":"2020","journal-title":"J\u00a0Am Coll Radiol"},{"issue":"12","key":"10.1016\/j.ejso.2023.107292_bib44","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.ejso.2019.07.011","article-title":"Pre-operative management of Pleomorphic and florid lobular carcinoma in situ of the breast: report of a large multi-institutional series and review of the literature","volume":"45","author":"Foschini","year":"2019","journal-title":"Eur J Surg Oncol : J Eur Soc Surg Oncol Brit Associat Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2023.107292_bib45","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrclinonc.2015.8","article-title":"Current management of lesions associated with an increased risk of breast cancer","volume":"12","author":"Morrow","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2023.107292_bib46","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1245\/s10434-015-4922-4","article-title":"Incidence of adjacent synchronous invasive carcinoma and\/or ductal carcinoma in-situ in patients with lobular neoplasia on core biopsy: results from a prospective multi-institutional registry (TBCRC 020)","volume":"23","author":"Nakhlis","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2023.107292_bib47","doi-asserted-by":"crossref","DOI":"10.1007\/s00428-022-03299-3","article-title":"The morphologic spectrum of lobular carcinoma in situ (LCIS) observations on clinical significance, management implications and diagnostic pitfalls of classic, florid and pleomorphic LCIS","author":"Brogi","year":"2022","journal-title":"Virchows Arch"},{"issue":"61","key":"10.1016\/j.ejso.2023.107292_bib48","doi-asserted-by":"crossref","first-page":"103047","DOI":"10.18632\/oncotarget.21461","article-title":"Treatment and survival outcomes of lobular carcinoma in situ of the breast: a SEER population based study","volume":"8","author":"Cheng","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.ejso.2023.107292_bib49","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1245\/s10434-018-6495-5","article-title":"Surgical management of lobular carcinoma in situ: analysis of the national cancer database","volume":"25","author":"Taylor","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2023.107292_bib50","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.breast.2021.07.020","article-title":"Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in The Netherlands: a population-based analysis","volume":"59","author":"van Maaren","year":"2021","journal-title":"Breast"},{"issue":"12","key":"10.1016\/j.ejso.2023.107292_bib51","doi-asserted-by":"crossref","first-page":"7696","DOI":"10.1245\/s10434-022-12066-2","article-title":"Presence of non-classic LCIS is not a contraindication to breast conservation in patients with concomitant invasive breast cancer or DCIS","volume":"29","author":"Nakhlis","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2023.107292_bib52","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.ijrobp.2013.08.012","article-title":"Risk of local failure in breast cancer patients with lobular carcinoma in situ at the final surgical margins: is re-excision necessary?","volume":"87","author":"Sadek","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejso.2023.107292_bib53","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.suronc.2019.01.009","article-title":"Breast-conserving surgery for pure non-classic lobular carcinoma in situ: a single institution's experience","volume":"28","author":"Hoffman","year":"2019","journal-title":"Surg Oncol"},{"key":"10.1016\/j.ejso.2023.107292_bib54","series-title":"Flat epithelial atypia of the breast: pathological-radiological correlation","author":"Solorzano","year":"2011"},{"issue":"7","key":"10.1016\/j.ejso.2023.107292_bib55","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1365-2559.2007.02700.x","article-title":"Flat epithelial atypia (DIN 1a, atypical columnar change): an underdiagnosed entity very frequently coexisting with lobular neoplasia","volume":"50","author":"Leibl","year":"2007","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.ejso.2023.107292_bib56","first-page":"270","article-title":"Atypia on breast core needle biopsies: reproducibility and significance","volume":"39","author":"Darvishian","year":"2009","journal-title":"Ann Clin Lab Sci"},{"issue":"2","key":"10.1016\/j.ejso.2023.107292_bib57","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/modpathol.3800514","article-title":"Interobserver reproducibility in the diagnosis of flat epithelial atypia of the breast","volume":"19","author":"O'Malley","year":"2006","journal-title":"Mod Pathol : Off J United States Canad Acad Pathol Inc."},{"key":"10.1016\/j.ejso.2023.107292_bib58","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1746-1596-9-121","article-title":"Inter-observer variability between general pathologists and a specialist in breast pathology in the diagnosis of lobular neoplasia, columnar cell lesions, atypical ductal hyperplasia and ductal carcinoma in situ of the breast","volume":"9","author":"Gomes","year":"2014","journal-title":"Diagn Pathol"},{"issue":"7","key":"10.1016\/j.ejso.2023.107292_bib59","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/jcp.2004.025239","article-title":"Pathological diagnosis of columnar cell lesions of the breast: are there issues of reproducibility?","volume":"58","author":"Tan","year":"2005","journal-title":"J\u00a0Clin Pathol"},{"issue":"1","key":"10.1016\/j.ejso.2023.107292_bib60","article-title":"Upgrade rate of pure flat epithelial atypia diagnosed at core needle biopsy: a systematic review and meta-analysis","volume":"3","author":"Wahab","year":"2021","journal-title":"Radiol Imag Cancer"},{"issue":"5","key":"10.1016\/j.ejso.2023.107292_bib61","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1515\/jom-2021-0206","article-title":"Upgrade rate of percutaneously diagnosed pure flat epithelial atypia: systematic review and meta-analysis of 1,924 lesions","volume":"122","author":"Ferre","year":"2022","journal-title":"J\u00a0Osteopath Med"},{"issue":"12","key":"10.1016\/j.ejso.2023.107292_bib62","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1245\/s10434-017-6059-0","article-title":"Flat epithelial atypia on core biopsy and upgrade to cancer: a systematic review and meta-analysis","volume":"24","author":"Rudin","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2023.107292_bib63","series-title":"Empfehlungen gyn\u00e4kologische Onkologie kommission mamma","year":"2022"},{"issue":"8","key":"10.1016\/j.ejso.2023.107292_bib64","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.crad.2019.04.006","article-title":"An audit of mammographic screen detected lesions of uncertain malignant potential (B3) diagnosed on initial image guided needle biopsy: how has our practice changed over 10 years?","volume":"74","author":"Batohi","year":"2019","journal-title":"Clin Radiol"},{"issue":"2","key":"10.1016\/j.ejso.2023.107292_bib65","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/PAS.0000000000001385","article-title":"Flat epithelial atypia in breast core needle biopsies with radiologic-pathologic concordance: is excision necessary?","volume":"44","author":"Grabenstetter","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.ejso.2023.107292_bib66","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s00330-020-07161-5","article-title":"Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended?","volume":"31","author":"Lucioni","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejso.2023.107292_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2020.109194","article-title":"Lesions of uncertain malignant potential of the breast (B3) on vacuum-assisted biopsy for microcalcifications: predictors of malignancy","volume":"130","author":"Mariscotti","year":"2020","journal-title":"Eur J Radiol"},{"issue":"2","key":"10.1016\/j.ejso.2023.107292_bib68","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000517109","article-title":"Malignancy rate and malignancy risk assessment in different lesions of uncertain malignant potential in the breast (B3 lesions): an analysis of 192 cases from a single institution","volume":"17","author":"Mohrmann","year":"2022","journal-title":"Breast Care"},{"key":"10.1016\/j.ejso.2023.107292_bib69","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.breast.2017.10.005","article-title":"Majority of flat epithelial atypia diagnosed on biopsy do not require surgical excision","volume":"37","author":"Chan","year":"2018","journal-title":"Breast"},{"issue":"2","key":"10.1016\/j.ejso.2023.107292_bib70","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10549-019-05481-9","article-title":"Flat epithelial atypia: are we being too aggressive?","volume":"179","author":"DiPasquale","year":"2020","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.ejso.2023.107292_bib71","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2214\/AJR.20.23935","article-title":"Malignant outcomes of architectural distortion on tomosynthesis: a systematic review and meta-analysis","volume":"217","author":"Choudhery","year":"2021","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.ejso.2023.107292_bib72","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.2214\/AJR.17.18156","article-title":"Radial scars of the breast encountered at core biopsy: review of histologic, imaging, and management considerations","volume":"209","author":"Cohen","year":"2017","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ejso.2023.107292_bib73","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.clinimag.2018.03.011","article-title":"Management of high-risk breast lesions found on mammogram or ultrasound: the value of contrast-enhanced MRI to exclude malignancy","volume":"49","author":"Hammersley","year":"2018","journal-title":"Clin Imag"},{"issue":"5","key":"10.1016\/j.ejso.2023.107292_bib74","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1007\/s00330-019-06586-x","article-title":"Can breast MRI accurately exclude malignancy in mammographic architectural distortion?","volume":"30","author":"Amitai","year":"2020","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.ejso.2023.107292_bib75","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1177\/0846537120930360","article-title":"Breast MRI does not help differentiating radial scar with and without associated atypia or malignancy","volume":"72","author":"Alsharif","year":"2021","journal-title":"Can Assoc Radiol J"},{"key":"10.1016\/j.ejso.2023.107292_bib76","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.clinimag.2017.07.003","article-title":"Clinical utility of contrast-enhanced spectral mammography as an adjunct for tomosynthesis-detected architectural distortion","volume":"46","author":"Patel","year":"2017","journal-title":"Clin Imag"},{"issue":"12","key":"10.1016\/j.ejso.2023.107292_bib77","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/jclinpath-2019-205764","article-title":"Outcome of radial scar\/complex sclerosing lesion associated with epithelial proliferations with atypia diagnosed on breast core biopsy: results from a multicentric UK-based study","volume":"72","author":"Rakha","year":"2019","journal-title":"J\u00a0Clin Pathol"},{"issue":"1","key":"10.1016\/j.ejso.2023.107292_bib78","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10549-018-5040-3","article-title":"Meta-analysis of upgrade rates in 3163 radial scars excised after needle core biopsy diagnosis","volume":"174","author":"Farshid","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"10.1016\/j.ejso.2023.107292_bib79","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1245\/s10434-021-09713-5","article-title":"Radial scars and complex sclerosing lesions of the breast: prevalence of malignancy and natural history under active surveillance","volume":"28","author":"Kraft","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2023.107292_bib80","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.ejso.2017.01.238","article-title":"Radial scar of the breast: is it possible to avoid surgery?","volume":"43","author":"Ferreira","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2023.107292_bib81","series-title":"Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study","author":"Groen","year":"2020"},{"issue":"2","key":"10.1016\/j.ejso.2023.107292_bib82","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2214\/AJR.11.7922","article-title":"Papillary lesions of the breast: MRI, ultrasound, and mammographic appearances","volume":"198","author":"Eiada","year":"2012","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.ejso.2023.107292_bib83","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00428-021-03182-7","article-title":"Papillary lesions of the breast","volume":"480","author":"Kulka","year":"2022","journal-title":"Virchows Arch"},{"issue":"2","key":"10.1016\/j.ejso.2023.107292_bib84","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2214\/AJR.16.16682","article-title":"Diagnostic performance of MRI versus galactography in women with pathologic nipple discharge: a systematic review and meta-analysis","volume":"209","author":"Berger","year":"2017","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.ejso.2023.107292_bib85","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/1066896914565023","article-title":"Exuberant squamous metaplasia in an intraductal papilloma of breast","volume":"23","author":"Ginter","year":"2015","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.ejso.2023.107292_bib86","series-title":"Pathology reporting of breast disease in surgical excision specimens incorporating the dataset for histological reporting of breast cancer","year":"2016"},{"issue":"9","key":"10.1016\/j.ejso.2023.107292_bib87","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00000478-200209000-00001","article-title":"Nonmalignant lesions in breast core needle biopsies: to excise or not to excise?","volume":"26","author":"Jacobs","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.ejso.2023.107292_bib88","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1177\/000313481207801033","article-title":"Intraductal papillary lesions of the breast: clinical and pathological correlation","volume":"78","author":"Shouhed","year":"2012","journal-title":"Am Surg"},{"key":"10.1016\/j.ejso.2023.107292_bib89","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.humpath.2020.10.012","article-title":"Upgrade rate of intraductal papilloma diagnosed on core needle biopsy in a single institution","volume":"110","author":"Lin","year":"2021","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.ejso.2023.107292_bib90","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/tbj.12907","article-title":"Papillary lesions of the breast: to excise or observe?","volume":"24","author":"Khan","year":"2018","journal-title":"Breast J"},{"issue":"2","key":"10.1016\/j.ejso.2023.107292_bib91","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/(SICI)1097-0142(19960715)78:2<258::AID-CNCR11>3.0.CO;2-V","article-title":"Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma","volume":"78","author":"Page","year":"1996","journal-title":"Cancer"},{"issue":"13","key":"10.1016\/j.ejso.2023.107292_bib92","doi-asserted-by":"crossref","first-page":"8643","DOI":"10.1245\/s10434-021-10188-7","article-title":"Upgrade rate and predictive factors for breast benign intraductal papilloma diagnosed at biopsy: a meta-analysis","volume":"28","author":"Zhang","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2023.107292_bib93","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejso.2017.10.214","article-title":"Management of benign papilloma without atypia diagnosed at ultrasound-guided core needle biopsy: scoring system for predicting malignancy","volume":"44","author":"Ahn","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2023.107292_bib94","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1245\/s10434-019-07180-7","article-title":"Benign papillary breast mass lesions: favorable outcomes with surgical excision or imaging surveillance","volume":"26","author":"Kuehner","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2023.107292_bib95","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1148\/radiol.2019190096","article-title":"Benign breast papilloma without atypia: outcomes of surgical excision versus US-guided directional vacuum-assisted removal or US follow-up","volume":"293","author":"Choi","year":"2019","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.ejso.2023.107292_bib96","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/tbj.12789","article-title":"Upgrade rate and imaging features of atypical apocrine lesions","volume":"23","author":"Chang Sen","year":"2017","journal-title":"Breast J"},{"key":"10.1016\/j.ejso.2023.107292_bib97","series-title":"AGO German commission breast, state of art guidelines 2022","year":"2022"},{"key":"10.1016\/j.ejso.2023.107292_bib98","series-title":"Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF. S3-Leitlinie Fr\u00fcherkennung, Diagnose, Therapie und Nachsorge des Mammakarzinoms","year":"2021"},{"issue":"2","key":"10.1016\/j.ejso.2023.107292_bib99","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10549-022-06631-2","article-title":"Excision of breast fibroepithelial lesions: when is it still necessary?-A 10-year review of a regional centre","volume":"194","author":"Mousa-Doust","year":"2022","journal-title":"Breast Cancer Res Treat"},{"issue":"9793","key":"10.1016\/j.ejso.2023.107292_bib100","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(11)60993-8","article-title":"Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials","volume":"378","author":"Davies","year":"2011","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ejso.2023.107292_bib101","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10549-012-2318-8","article-title":"The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions","volume":"136","author":"Coopey","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejso.2023.107292_bib102","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s12609-014-0144-1","article-title":"Advances in preventive therapy for estrogen-receptor-negative breast cancer","volume":"6","author":"Litzenburger","year":"2014","journal-title":"Curr Breast Cancer Rep"},{"issue":"6","key":"10.1016\/j.ejso.2023.107292_bib103","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0002-9440(10)65498-3","article-title":"Estrogen receptor-positive proliferating cells in the normal and precancerous breast","volume":"155","author":"Shoker","year":"1999","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.ejso.2023.107292_bib104","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.3892\/or.2016.4988","article-title":"Expression pattern and methylation of estrogen receptor \u03b1 in breast intraductal proliferative lesions","volume":"36","author":"Mao","year":"2016","journal-title":"Oncol Rep"},{"issue":"4","key":"10.1016\/j.ejso.2023.107292_bib105","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jnci\/djk050","article-title":"Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial","volume":"99","author":"Powles","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"18","key":"10.1016\/j.ejso.2023.107292_bib106","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study","volume":"90","author":"Fisher","year":"1998","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.ejso.2023.107292_bib107","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/jnci\/djk154","article-title":"Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy","volume":"99","author":"Veronesi","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.ejso.2023.107292_bib108","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/jnci\/djk049","article-title":"Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial","volume":"99","author":"Cuzick","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"9122","key":"10.1016\/j.ejso.2023.107292_bib109","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(98)85012-5","article-title":"Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial","volume":"352","author":"Powles","year":"1998","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.ejso.2023.107292_bib110","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/jnci\/dji372","article-title":"Tamoxifen for the prevention of breast cancer: current status of the national surgical adjuvant breast and bowel project P-1 study","volume":"97","author":"Fisher","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"19","key":"10.1016\/j.ejso.2023.107292_bib111","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1200\/JCO.18.01779","article-title":"Randomized placebo controlled trial of low-dose tamoxifen to prevent local and contralateral recurrence in breast intraepithelial neoplasia","volume":"37","author":"DeCensi","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"9880","key":"10.1016\/j.ejso.2023.107292_bib112","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0140-6736(13)60140-3","article-title":"Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data","volume":"381","author":"Cuzick","year":"2013","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.ejso.2023.107292_bib113","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"issue":"10218","key":"10.1016\/j.ejso.2023.107292_bib114","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(19)32955-1","article-title":"Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial","volume":"395","author":"Cuzick","year":"2020","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.ejso.2023.107292_bib115","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1056\/NEJMoa1103507","article-title":"Exemestane for breast-cancer prevention in postmenopausal women","volume":"364","author":"Goss","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ejso.2023.107292_bib116","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/annonc\/mdv590","article-title":"Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis","volume":"27","author":"Smith","year":"2016","journal-title":"Ann Oncol"},{"issue":"18","key":"10.1016\/j.ejso.2023.107292_bib117","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1200\/JCO.2009.27.8077","article-title":"Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis","volume":"28","author":"Ropka","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2023.107292_bib118","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10549-022-06577-5","article-title":"Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen","volume":"193","author":"Bychkovsky","year":"2022","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"10.1016\/j.ejso.2023.107292_bib119","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1470-2045(11)70122-X","article-title":"Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial","volume":"12","author":"Gnant","year":"2011","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2023.107292_bib120","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/jama.2019.11885","article-title":"Medication use to reduce risk of breast cancer: US preventive services Task Force recommendation statement","volume":"322","author":"Owens","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.ejso.2023.107292_bib121","series-title":"Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer","year":"2019"},{"issue":"1","key":"10.1016\/j.ejso.2023.107292_bib122","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.annonc.2022.10.004","article-title":"Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline","volume":"34","author":"Sessa","year":"2023","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2023.107292_bib123","first-page":"CD012110","article-title":"Body weight management in overweight and obese breast cancer survivors","volume":"12","author":"Shaikh","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ejso.2023.107292_bib124","first-page":"CD011292","article-title":"Physical activity for women with breast cancer after adjuvant therapy","volume":"1","author":"Lahart","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"9499","key":"10.1016\/j.ejso.2023.107292_bib125","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/S0140-6736(05)67725-2","article-title":"Comparative Risk Assessment collaborating g. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors","volume":"366","author":"Danaei","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejso.2023.107292_bib126","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0002-9378(90)90420-C","article-title":"The antiestrogenic effect of cigarette smoking in women","volume":"162","author":"Baron","year":"1990","journal-title":"Am J Obstet Gynecol"},{"issue":"17","key":"10.1016\/j.ejso.2023.107292_bib127","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1056\/NEJM198210213071707","article-title":"Cigarette smoking and urinary estrogens","volume":"307","author":"MacMahon","year":"1982","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.ejso.2023.107292_bib128","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJM198806303182601","article-title":"Cigarette smoking and levels of adrenal androgens in postmenopausal women","volume":"318","author":"Khaw","year":"1988","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.ejso.2023.107292_bib129","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/ntr\/ntac066","article-title":"A\u00a0systematic review and meta-analysis of smoking and circulating sex hormone levels among premenopausal women","volume":"24","author":"Ihenacho","year":"2022","journal-title":"Nicotine Tob Res"},{"issue":"4","key":"10.1016\/j.ejso.2023.107292_bib130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10654-005-0385-4","article-title":"Smoking as a determinant for plasma levels of testosterone, androstenedione, and DHEAs in postmenopausal women","volume":"20","author":"Manjer","year":"2005","journal-title":"Eur J Epidemiol"},{"issue":"8","key":"10.1016\/j.ejso.2023.107292_bib131","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/jnci\/94.8.606","article-title":"Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies","volume":"94","author":"Key","year":"2002","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.ejso.2023.107292_bib132","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S1470-2045(13)70301-2","article-title":"Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies","volume":"14","author":"Endogenous","year":"2013","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2023.107292_bib133","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/jnci\/djt023","article-title":"Active smoking and breast cancer risk: original cohort data and meta-analysis","volume":"105","author":"Gaudet","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"2\u20133","key":"10.1016\/j.ejso.2023.107292_bib134","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/em.10046","article-title":"Smoking (active and passive) and breast cancer: epidemiologic evidence up to June 2001","volume":"39","author":"Morabia","year":"2002","journal-title":"Environ Mol Mutagen"},{"issue":"11","key":"10.1016\/j.ejso.2023.107292_bib135","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/sj.bjc.6600596","article-title":"Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease","volume":"87","author":"Hamajima","year":"2002","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2023.107292_bib136","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10549-015-3628-4","article-title":"Active and passive smoking and risk of breast cancer: a meta-analysis","volume":"154","author":"Macacu","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"10.1016\/j.ejso.2023.107292_bib137","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1038\/bjc.2014.132","article-title":"Cigarette smoking and postmenopausal breast cancer risk in a prospective cohort","volume":"110","author":"Nyante","year":"2014","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.ejso.2023.107292_bib138","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41574-021-00487-0","article-title":"Metabolic pathways in obesity-related breast cancer","volume":"17","author":"Brown","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"10.1016\/j.ejso.2023.107292_bib139","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3322\/caac.21405","article-title":"Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention","volume":"67","author":"Picon-Ruiz","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.ejso.2023.107292_bib140","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/jnci\/djq526","article-title":"Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies","volume":"103","author":"Yang","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.ejso.2023.107292_bib141","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/epirev\/mxt010","article-title":"Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status","volume":"36","author":"Munsell","year":"2014","journal-title":"Epidemiol Rev"},{"issue":"7630","key":"10.1016\/j.ejso.2023.107292_bib142","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1136\/bmj.39367.495995.AE","article-title":"Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study","volume":"335","author":"Reeves","year":"2007","journal-title":"BMJ"},{"issue":"17","key":"10.1016\/j.ejso.2023.107292_bib143","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ejso.2023.107292_bib144","article-title":"Factors for the primary prevention of breast cancer: a meta-analysis of prospective cohort studies","volume":"21","author":"Poorolajal","year":"2021","journal-title":"J\u00a0Res Health Sci"},{"issue":"3","key":"10.1016\/j.ejso.2023.107292_bib145","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s10549-012-2396-7","article-title":"Physical activity and risk of breast cancer: a meta-analysis of prospective studies","volume":"137","author":"Wu","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.ejso.2023.107292_bib146","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jval.2018.06.020","article-title":"Physical activity and risk of breast cancer: a meta-analysis of 38 cohort studies in 45 study reports","volume":"22","author":"Chen","year":"2019","journal-title":"Value Health"},{"issue":"21","key":"10.1016\/j.ejso.2023.107292_bib147","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/jnci\/dji341","article-title":"Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study","volume":"97","author":"Suzuki","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.ejso.2023.107292_bib148","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/alcalc\/agab042","article-title":"Alcohol consumption is a modifiable risk factor for breast cancer: are women aware of this relationship?","volume":"57","author":"Agabio","year":"2022","journal-title":"Alcohol Alcohol"},{"issue":"7","key":"10.1016\/j.ejso.2023.107292_bib149","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s10654-022-00886-1","article-title":"Alcohol consumption, blood DNA methylation and breast cancer: a Mendelian randomisation study","volume":"37","author":"Zhou","year":"2022","journal-title":"Eur J Epidemiol"},{"issue":"8","key":"10.1016\/j.ejso.2023.107292_bib150","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/s41416-021-01492-w","article-title":"Trajectories of alcohol consumption during life and the risk of developing breast cancer","volume":"125","author":"Donat-Vargas","year":"2021","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2023.107292_bib151","first-page":"11","article-title":"Alcohol's effects on breast cancer in women","volume":"40","author":"Freudenheim","year":"2020","journal-title":"Alcohol Res"},{"issue":"5","key":"10.1016\/j.ejso.2023.107292_bib152","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/s13058-014-0446-2","article-title":"Risk determination and prevention of breast cancer","volume":"16","author":"Howell","year":"2014","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ejso.2023.107292_bib153","series-title":"Diet, nutrition, physical activity and cancer: a global perspective","author":"WcrfaifC","year":"2018"},{"issue":"2","key":"10.1016\/j.ejso.2023.107292_bib154","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/ije\/dyy238","article-title":"Foods, macronutrients and breast cancer risk in postmenopausal women: a large UK cohort","volume":"48","author":"Key","year":"2019","journal-title":"Int J Epidemiol"},{"issue":"8","key":"10.1016\/j.ejso.2023.107292_bib155","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/ijc.31575","article-title":"Alcohol, smoking, and risk of Her2-overexpressing and triple-negative breast cancer relative to estrogen receptor-positive breast cancer","volume":"143","author":"Baglia","year":"2018","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2023.107292_bib156","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/ije\/dyv156","article-title":"Alcohol consumption and breast cancer risk by estrogen receptor status: in a pooled analysis of 20 studies","volume":"45","author":"Jung","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"3","key":"10.1016\/j.ejso.2023.107292_bib157","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ijc.32324","article-title":"Mediation analysis of the alcohol-postmenopausal breast cancer relationship by sex hormones in the EPIC cohort","volume":"146","author":"Assi","year":"2020","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2023.107292_bib158","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10549-015-3393-4","article-title":"Prospective evaluation of alcohol consumption and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"151","author":"Cybulski","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejso.2023.107292_bib159","first-page":"729","volume":"vol. 41","author":"Stacey","year":"2021"},{"issue":"9","key":"10.1016\/j.ejso.2023.107292_bib160","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1245\/s10434-017-5867-6","article-title":"Population-based analysis of breast cancer incidence and survival outcomes in women diagnosed with lobular carcinoma in situ","volume":"24","author":"Wong","year":"2017","journal-title":"Ann Surg Oncol"}],"updated-by":[{"DOI":"10.1016\/j.ejso.2023.107943","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000}}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798323009307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798323009307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T08:32:01Z","timestamp":1705134721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798323009307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":160,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0748798323009307"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2023.107292","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2023.107292","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107292"}}